HUS1 and ovarian cancer: On the contrary, downregulation of HUS1 by antisense oligonucleotides enhances the sensitivity of human lung carcinoma cells to cisplatin [45] and high HUS1 expression is significantly correlated with poor prognostic clinicopathologic factors in ovarian cancer [32].